Mostrar el registro sencillo del ítem

dc.contributor.authorD’Marco, Luis
dc.contributor.authorCortez, Marie
dc.contributor.authorSalazar, María
dc.contributor.authorLima-Martínez, Marcos
dc.contributor.authorBermúdez, Valmore
dc.date.accessioned2020-03-24T20:25:05Z
dc.date.available2020-03-24T20:25:05Z
dc.date.issued2020
dc.identifier.issn02149168
dc.identifier.urihttps://hdl.handle.net/20.500.12442/5056
dc.description.abstractLa enfermedad renal crónica representa un verdadero estado inflamatorio y está relacionada con múltiples factores de riesgo cardiovascular. La enfermedad arterial coronaria es una de sus principales complicaciones y usualmente ha sido asociada con factores de riesgo cardiovascular no clásicos o propios de pacientes urémicos como las alteraciones del metabolismo del calcio y el fósforo, entre otros. Evidencia clínica reciente muestra que el depósito de grasa órgano específico, como el tejido adiposo epicárdico, es un factor de riesgo adicional a tener en cuenta en el momento de la evaluación de riesgo cardiovascular en la población general y en los pacientes renales. La interacción directa de este tejido con los vasos coronarios y la consecuente mediación de sustancias proaterogénicas generan un proceso local que termina en la producción de daño endotelial. Aunque la población de enfermos renales ha sido evaluada escasamente, estudios futuros determinarán con precisión si un incremento en la adiposidad epicárdica está verdaderamente asociado a la morbimortalidad cardiovascular en este grupo de riesgo.spa
dc.description.abstractChronic kidney disease represents a true inflammatory state, and is related to multiple cardiovascular risk factors. Coronary artery disease is the major complication, and has usually been associated with non-classical or uraemic related factors that include the disturbance of calcium and phosphorus metabolism, among others. Recent clinical evidence shows that specific body fat deposition like epicardial adipose tissue is an additional factor to consider when evaluating cardiovascular risk in the general population and kidney patients. Direct interaction of this tissue and coronary vessels with consequent mediation of pro-atherogenic substances have a local process ending in endothelial damage. Although the population of renal patients has been poorly evaluated, future studies should determine precisely whether an increase in epicardial fat is truly associated with cardiovascular morbidity and mortality in this risk group.eng
dc.format.mimetypepdfspa
dc.language.isospaspa
dc.publisherElsevierspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceClínica e Investigación en Arteriosclerosisspa
dc.sourceClin Investig Arterioscleeng
dc.sourceArteri-515 (2020)eng
dc.source.urihttps://doi.org/10.1016/j.arteri.2019.10.006
dc.subjectEnfermedad renal crónicaspa
dc.subjectTejido adiposo epicárdicospa
dc.subjectRiesgo cardiovascularspa
dc.subjectCalcificaciones vascularesspa
dc.subjectChronic kidney diseaseeng
dc.subjectEpicardial adipose tissueeng
dc.subjectCardiovascular riskeng
dc.subjectVascular calcificationeng
dc.titleTejido adiposo epicárdico: un marcador de riesgo cardiovascular a evaluar en la enfermedad renal crónicaspa
dc.typearticleeng
dcterms.referencesTonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol [Internet]. 2006;17:2034---47. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16738019.eng
dcterms.referencesSarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension. 2003;42:1050---65.eng
dcterms.referencesBerl T, Henrich W. Kidney-heart interactions: Epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol [Internet]. 2006;1:8---18. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/17699186.eng
dcterms.referencesKramer H, Toto R, Peshock R, Cooper R, Victor R. Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study. J Am Soc Nephrol. 2005;16:507---13.eng
dcterms.referencesCôté N, Pibarot P, Pépin A, Fournier D, Audet A, Arsenault B, et al. Oxidized low-density lipoprotein, angiotensin and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis. Int J Cardiol [Internet]. 2010;145:444---9. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19525020. 6eng
dcterms.referencesMathieu P, Poirier P, Pibarot P, Lemieux I, Després JP. Visceral obesity: The link among inflammation, hypertension, and cardiovascular disease. Hypertens (Dallas, Tex 1979) [Internet]. 2009;53:577---84. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19237685.eng
dcterms.referencesKershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab [Internet]. 2004;89:2548---56. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/15181022.eng
dcterms.referencesBornachea O, Vea A, Llorente-Cortes V. Interplay between epicardial adipose tissue, metabolic and cardiovascular diseases. Clin e Investig en Arterioscler [Internet]. 2018;30:230---9, http://dx.doi.org/10.1016/j.arteri.2018.03.003.eng
dcterms.referencesWu Y, Zhang A, Hamilton DJ, Deng T. Epicardial fat in the maintenance of cardiovascular health. Methodist Debakey Cardiovasc J [Internet]. 13(1):20-24. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/28413578.eng
dcterms.referencesOikawa M, Owada T, Yamauchi H, Misaka T, Machii H, Yamaki T, et al. Epicardial adipose tissue reflects the presence of coronary artery disease: Comparison with abdominal visceral adipose tissue. Biomed Res Int [Internet]. 2015;2015:483982. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25692138.eng
dcterms.referencesNagy E, Jermendy AL, Merkely B, Maurovich-Horvat P. Clinical importance of epicardial adipose tissue. Arch Med Sci [Internet]. 2017;13:864---74. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/28721155.eng
dcterms.referencesIacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: Anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2:536---43.eng
dcterms.referencesDe Feyter PJ. Epicardial adipose tissue: An emerging role for the development of coronary atherosclerosis. Clin Cardiol. 2011;34:143---4.eng
dcterms.referencesIacobellis G, Bianco AC. Epicardial adipose tissue: Emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab [Internet]. 2011;22:450---7, http://dx.doi.org/10.1016/j.tem.2011.07.003.eng
dcterms.referencesIacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005;29:251---5.eng
dcterms.referencesUeno K, Anzai T, Jinzaki M, Yamada M, Jo Y, Maekawa Y, et al. Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ J. 2009;73:1927---33.eng
dcterms.referencesPierdomenico SD, Pierdomenico AM, Cuccurullo F, Iacobellis G. Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome. Am J Cardiol [Internet]. 2013;111:73---8, http://dx.doi.org/10.1016/j.amjcard.2012.08.044.eng
dcterms.referencesDjaberi R, Schuijf JD, van Werkhoven JM, Nucifora G, Jukema JW, Bax JJ. Relation of epicardial adipose tissue to coronary atherosclerosis. Am J Cardiol [Internet]. 2008;102:1602---7, http://dx.doi.org/10.1016/j.amjcard.2008.08.010.eng
dcterms.referencesKarohl C, D’Marco L, Bellasi A, Raggi P. Hybrid myocardial imaging for risk stratification prior to kidney transplantation: Added value of coronary calcium and epicardial adipose tissue. J Nucl Cardiol. 2013;20:1013---20.eng
dcterms.referencesIacobellis G. Epicardial and pericardial fat: Close, but very different. Obesity (Silver Spring) [Internet]. 2009;17:625 [author reply 626-7]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19322142.eng
dcterms.referencesRabkin SW. Epicardial fat: Properties, function and relationship to obesity. Obes Rev. 2007;8:253---61.eng
dcterms.referencesHajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J [Internet]. 2008;29:2959---71. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18775919.eng
dcterms.referencesWang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm [Internet]. 2010;2010:535918. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20847813.eng
dcterms.referencesNakagawa Y, Nishikimi T, Kuwahara K. Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides [Internet]. 2019;111:18---25. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/29859763.eng
dcterms.referencesNakagawa H, Oberwinkler H, Nikolaev VO, Gaßner B, Umbenhauer S, Wagner H, et al. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation. Circ Heart Fail [Internet]. 2014;7:814---21. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25027872.eng
dcterms.referencesD’Marco L, Bellasi A, Raggi P. Cardiovascular biomarkers in chronic kidney disease: State of current research and clinical applicability. Dis Markers. 2015;2015:1---16.eng
dcterms.referencesBordicchia M, Liu D, Amri E-Z, Ailhaud G, Dessì-Fulgheri P, Zhang C, et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest [Internet]. 2012;122:1022---36. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22307324.eng
dcterms.referencesSengenes C, Stich V, Berlan M, Hejnova J, Lafontan M, Pariskova Z, et al. Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women. Int J Obes Relat Metab Disord [Internet]. 2002;26:24---32. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11791143.eng
dcterms.referencesMatsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A [Internet]. 1999;96:7403---8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/10377427eng
dcterms.referencesTurkmen K, Kayikcioglu H, Ozbek O, Solak Y, Kayrak M, Samur C, et al. The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol. 2011;6:1920---5.eng
dcterms.referencesKerr JD, Holden RM, Morton AR, Nolan RL, Hopman WM, Pruss CM, et al. Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease. BMC Nephrol [Internet]. 2013;14:26. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23351146.eng
dcterms.referencesKaratas A, Canakci E, Bektas O, Bayrak T, Bayrak A, Altinbas A, et al. Relationship of epicardial fat tissue thickness with oxidant biomarkers in chronic kidney disease. Bratisl Lek Listy [Internet]. 2018;119(9):566-571. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/30226067.eng
dcterms.referencesD’Marco LG, Bellasi A, Kim S, Chen Z, Block GA, Raggi P. Epicardial adipose tissue predicts mortality in incident hemodialysis patients: A substudy ofthe Renagel in New Dialysis trial. Nephrol Dial Transplant. 2013;28:2586---95.eng
dcterms.referencesNakanishi K, Fukuda S, Tanaka A, Otsuka K, Taguchi H, Yoshikawa J, et al. Epicardial adipose tissue accumulation is associated with renal dysfunction and coronary plaque morphology on multidetector computed tomography. Circ J. 2015;80:196---201.eng
dcterms.referencesCordeiro AC, Amparo FC, Oliveira MAC, Amodeo C, Smanio P, Pinto IMF, et al. Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3-5 chronic kidney disease. J Intern Med. 2015;278:77---87.eng
dcterms.referencesKo SM, Zhang C, Chen Z, D’Marco L, Bellasi A, Stillman AE, et al. Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: A substudy of the Renagel in new dialysis trial. J Nephrol. 2016;29:683---90.eng
dcterms.referencesYazbek DC, Carvalho AB, Barros CS, Pestana JOM, Rochitte CE, dos Santos Filho RD, et al. Is there relationship between epicardial fat and cardiovascular parameters in incident kidney transplant patients? A post-hoc analysis. PLoS One. 2018;13:1---11.eng
dcterms.referencesGau S, Klinghammer L, Jahn D, Schuhbäck A, Achenbach S, Marwan M. Epicardial fat and coronary artery calcification in patients on long-term hemodialysis. J Comput Assist Tomog [Internet]. 2014;38(5):768-772. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24879458.eng
dcterms.referencesAyan H, Akilli R, Kaya B, Paydas S, Kara E, Cureoglu A. Relationship between scube1 levels and echocardiography and electrocardiography findings and epicardial adipose tissue/carotid intima-media thickness in patients receiving renal replacement therapy. Exp Clin Transplant. 2019;17 Suppl 1:181---7.eng
dcterms.referencesSag S, Yildiz A, Gullulu S, Gungoren F, Ozdemir B, Cegilli E, et al. Early atherosclerosis in normotensive patients with autosomal dominant polycystic kidney disease: The relation between epicardial adipose tissue thickness and carotid intima-media thickness. Springerplus [Internet]. 2016;5:211. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/27026905.eng
dcterms.referencesBravo Ramírez AM, Chevaile Ramos A, Hurtado Torres GF. [Body composition in chronic kidney disease patients and haemodialysis]. Nutr Hosp [Internet]. 2010;25:245---9. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20449533.eng
dcterms.referencesMancini A, Grandaliano G, Magarelli P, Allegretti A. Nutritional status in hemodialysis patients and bioimpedance vector analysis. J Ren Nutr [Internet]. 2003;13:199---204. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/12874744.eng
dcterms.references43. Pupim LB, Ikizler TA. Assessment and monitoring of uremic malnutrition. J Ren Nutr [Internet]. 2004;14:6---19. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/14740325.eng
dcterms.references44. Chazot C, Gassia J-P, di Benedetto A, Cesare S, Ponce P, Marcelli D. Is there any survival advantage of obesity in Southern European haemodialysis patients? Nephrol Dial Transplant [Internet]. 2009;24:2871---6. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19369686.eng
dcterms.referencesLeavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in ‘‘healthier’’ as compared with ‘‘sicker’’ haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant [Internet]. 2001 Dec;16:2386---94. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11733631.eng
dcterms.referencesJanssen I, Katzmarzyk PT, Ross R. Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc [Internet]. 2005;53:2112---8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16398895.eng
dcterms.referencesFonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. ADHERE Scientific Advisory Committee and Investigators An obesity paradox in acute heart failure: Analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J [Internet]. 2007;153:74---81. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/17174642.eng
dcterms.referencesIkizler TA. Effects of hemodialysis on protein metabolism. J Ren Nutr [Internet]. 2005;15:39---43. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/15648005.eng
dcterms.referencesDai L, Golembiewska E, Lindholm B, Stenvinkel P. Endstage renal disease inflammation and cardiovascular outcomes. Contrib Nephrol [Internet]. 2017;191:32---43. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/28910789.eng
dcterms.references50. Naderi N, Kleine C-E, Park C, Hsiung J-T, Soohoo M, Tantisattamo E, et al. Obesity paradox in advanced kidney disease: From bedside to the bench. Prog Cardiovasc Dis [Internet]. 2018;61(2):168-181. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/29981348.eng
dcterms.references51. Park J, Ahmadi SF, Streja E, Molnar MZ, Flegal KM, Gillen D, et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis [Internet]. 2014;56:415---25. Disponible en: https://doi.org/10.1016/j.pcad.2013.10.005.eng
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccessspa
oaire.versioninfo:eu-repo/semantics/publishedVersionspa
dc.type.driverarticleeng
dc.title.translatedEpicardial adipose tissue: A cardiovascular risk marker to evaluate in chronic kidney diseaseeng


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional